D. E. Shaw & Co., Inc. Candel Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.13 - $5.56 $34,013 - $60,420	-10,867 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.66 - $8.0 $2,726 - $5,960	745 Added 7.36%	10,867 $55,000
Q4 2021 Feb 14, 2022	BUY	$6.34 - $11.9 $64,173 - $120,451	10,122 New	10,122 $79,000

6.41M

109K

130K

Ticker CADL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,891,900
Market Cap $256M
Description
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.